Adrenocortical scintigraphy with 131I-6-beta-iodomethyl-norcholesterol (NP 59) in bilateral adrenocortical carcinoma.
A case of a 49-year-old man suffering from bilateral adrenocortical carcinoma with local and secondary rapid progression is reported. The results of adrenocortical scintigraphy (NP 59) and histological findings allowed the diagnosis. This case report and a literature review showed the importance of using adrenocortical scintigraphy as a complementary imaging procedure of CT or MR images.
Ruíz Hernández
G
G
Servei de Medicina Nuclear, Hospital Clínic Universitari de València, Spain.
Pallarés
F J
FJ
Bartual
A R
AR
Tenes Rodrigo
S
S
Ampudia-Blasco
F J
FJ
de Avila y Avalos
C R
CR
D015071:19-Iodocholesterol / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000306:Adrenal Cortex Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000601:surgery; D000315:Adrenalectomy; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D008939:Mitotane / Q000627:therapeutic use; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D014057:Tomography, X-Ray Computed
D018931:Antineoplastic Agents, Hormonal; D019275:Radiopharmaceuticals; D015071:19-Iodocholesterol; C035501:6-iodomethylcholesterol; D008939:Mitotane